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Abstract
Background: Childhood asthma prevalence is widely measured by parental proxy report of physician-diagnosed
asthma in questionnaires. Our objective was to validate this measure in a North American population.
Methods: The 2884 study participants were a subsample of 5619 school children aged 5 to 9 years from 231
schools participating in the Toronto Child Health Evaluation Questionnaire study in 2006. We compared agreement
between “questionnaire diagnosis” and a previously validated “health claims data diagnosis”. Sensitivity, specificity
and kappa were calculated for the questionnaire diagnosis using the health claims diagnosis as the reference
standard.
Results: Prevalence of asthma was 15.7% by questionnaire and 21.4% by health claims data. Questionnaire
diagnosis was insensitive (59.0%) but specific (95.9%) for asthma. When children with asthma-related symptoms
were excluded, the sensitivity increased (83.6%), and specificity remained high (93.6%).
Conclusions: Our results show that parental report of asthma by questionnaire has low sensitivity but high
specificity as an asthma prevalence measure. In addition, children with “asthma-related symptoms” may represent a
large fraction of under-diagnosed asthma and they should be excluded from the inception cohort for risk factor
studies.
Background
Parental proxy report of physician-diagnosed asthma
(questionnaire diagnosis) is the standard measure of child-
hood asthma prevalence used in national health surveys
and epidemiological studies. The International Study of
Allergies and Asthma in Childhood (ISAAC) questionnaire
is the current gold standard for ascertaining asthma out-
comes in epidemiologic studies [1]. The “ever wheeze”
question is often used to compare asthma prevalence
between countries. For international studies, a symptom-
based definition is less subject to bias than a diagnosis-
based definition [2]. However, for national studies that
evaluate risk factors, a more specific definition is often
desired [3-5]. In these studies, lifetime asthma is measured
by affirmative response to the question: “Has your child
ever had asthma?” and is further defined to be “Doctor
diagnosed asthma” i ft h e r ei sa na f f i r m a t i v er e s p o n s et o
the question “H a st h i sb e e nd i a g n o s e db yad o c t o r ? ”
Despite its widespread use in studies assessing asthma
prevalence [2], risk factors [6],and diagnostic tests [7] this
questionnaire based asthma diagnosis has not been vali-
dated in a North American population.
Canada has a universal health care system in which all
Canadians have equal access to physician and hospital
services. Health claims data on all patient encounters is
collected for administrative purposes although in Ontario
there is currently no centralized database on prescription
medication. These databases have been found to be accu-
rate compared to chart abstraction for diseases such as
ischemic heart disease [8], esophagitis [9] as well as
asthma [10]. Recently, an algorithm has been developed
to identify children with asthma from health claims data
i nt h ep r o v i n c eo fO n t a r i o .T h i sa l g o r i t h m ,h a sb e e n
shown to have 91.4% sensitivity and 82.9% specificity for
correctly identifying asthma when compared to expert
consensus diagnosis of asthma [10,11].
The objective of this research was to assess agreement
between questionnaire based parental proxy report of
physician diagnosed asthma in children (hereafter
referred to as “questionnaire diagnosis”)a n da s t h m a
diagnosed by analyzing health claims data (hereafter
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Methods
Subjects
Participants were recruited from The Toronto Child
Health Evaluation Questionnaire (T-CHEQ) study. This
study used ISAAC methodology [1] to recruit a popula-
tion based sample of 5619 children (aged 5 to 9 years)
from 231 Toronto public schools between January and
May of 2006. The demographic characteristics of these
children closely resembled census data [12] and the pre-
valence of asthma outcomes closely resembled national
health survey data [12]. Detailed methods for sampling
and recruitment are published elsewhere [12]. All sub-
jects that participated in the T-CHEQ study were asked
at the time of the initial study if they would consent to
have their child’s questionnaire linked to health claims
data for research purposes and those that agreed were
included in this study.
Study Design
This is a diagnostic validation study, comparing agreement
between questionnaire asthma diagnosis (using data from
the cross-sectional T-CHEQ study) and health claims
diagnosis (using cohort data from lifetime health claims
administrative databases).
Questionnaire based Asthma diagnosis
Asthma diagnosis was identified from the T-CHEQ study
sample by affirmative responses to the questions “Has
your child ever had asthma?” and “Was this diagnosed by
ad o c t o r ? ” Those that reported non-physician diagnosed
asthma were excluded from the analysis. Non-asthma
controls did not report doctor diagnosed asthma. These
controls were further categorized into those with
“Asthma-related symptoms” if they reported a yes
response to either “Has your child ever had wheezing” or
“In the past 12 months has your child had a dry cough at
night, apart from a cough associated with a cold or chest
infection?”.
Health Claims Asthma Diagnosis (Reference Standard)
Health claims data between March 31, 1997 and March
31, 2006 (i.e. the child’s lifetime) from two Ontario health
care administrative databases were used: (1) the Canadian
Institute for Health Information (CIHI) discharge
abstract database for inpatient services and (2) The
Ontario Health Insurance Plan (OHIP) for ambulatory
and emergency services. Both of these databases contain
diagnostic codes based on the International Classification
of Disease (ICD)-9 or 10. A claim for asthma was identi-
fied by the ICD- 9 code 493 for claims up to March 31,
2002 and ICD-10 codes J45 and J46 identified asthma in
subsequent years. The CIHI database currently allows up
to 25 diagnostic codes (prior to 2002, 16 diagnostic codes
were allowed) and if any of these was for asthma, the
hospitalization was included. The OHIP database allows
o n ed i a g n o s t i cc o d ep e rv i s i t. Only one claim per physi-
cian per day per patient was allowed. The health claims
databases were also linked to the Registered Persons
Database which contains mortality and demographic data
to ensure that the subjects had lived within the province
since birth. A unique personal identifier (the scrambled
Health Card Number) included in each database permits
t h el i n k a g eo fac h i l d ’sr e c o r d sa c r o s sa l ld a t a b a s e sa n d
time while preserving patient confidentiality.
Prevalent asthma cases were defined by a previously vali-
dated algorithm as follows: at least one hospitalization for
asthma at any time during the child’s life or two separate
ambulatory or emergency room visits for asthma within a
two year time frame [11]. This algorithm was previously
found to have optimal diagnostic parameters using an
expert consensus diagnosis from chart abstraction [10,11].
Data linkage
The T-CHEQ participants were anonymously linked to
the health claims databases through their reported Health
Insurance Number. A matching date of birth in the two
databases was also needed for the link to be considered
valid. All data linkage and analysis related to this study
was completed within the secure confines of the Institute
of Clinical and Evaluative Sciences in Toronto, Ontario.
Statistical methods
“Questionnaire diagnosis” and “health claims diagnosis”
were compared in two by two tables. Sensitivity and speci-
ficity of the questionnaire diagnosis were calculated using
health claims diagnosis as the gold standard. In order to
test the potential misclassification bias that could occur by
including children with asthma-related symptoms in the
non-asthma control group, the children with asthma-
related symptoms were removed from the sample and sen-
sitivities and specificities were recalculated. Additional
sensitivity analyses were conducted by modifying the
health claims data algorithm (increasing the time frame
for incident asthma ambulatory claims from 2 to 3 years
or including emergency visit data from an additional data-
base). We also calculated agreement (kappa) [13] between
questionnaire and health claims diagnosis.
Ethical Approval
Parents of children in this study gave informed consent for
participation in this research by filling in the voluntary T-
CHEQ questionnaire and additionally agreeing to partici-
pate in the data linkage. This study was approved by the
Research Ethics Board of the Hospital for Sick Children in
Toronto.
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Baseline characteristics
From the original TCHEQ cohort, 2884 (51.32%) gave
permission to link to health claims data. Respondents
did not differ from non-respondents in terms of asthma
prevalence or gender, however they were more likely to
be in a higher income group (42.13% versus 31.40%)
and have post-graduate education (51.96% versus
40.09%), and were less likely to report no physician vis-
its in the past year (24.85% versus 29.57%) (Table 1).
Data linkage was successfully achieved in 2782 of the
respondents (96.46%).
Asthma prevalence
In our study sample, 437 children were identified with
questionnaire diagnosis of asthma (prevalence of
15.71%) while 586 children were identified with health
claims diagnosis of asthma (prevalence of 21.06%)
(Table 2). The vast majority of subjects with ever
asthma (defined by the question “Has your child ever
had asthma?”) had physician diagnosed asthma (also
responded affirmatively to the question “Was this diag-
nosed by a doctor?”) (prevalence of asthma 16.41% and
15.71% respectively).
Questionnaire accuracy
The questionnaire diagnosis had a sensitivity of 59.04%
and a specificity of 95.86% for detecting asthma using
the health claims diagnosis as the reference standard.
Of the 2435 non-asthma controls, 854 (35%) had
asthma-related symptoms. When these children were
removed from the sample (table 3), the sensitivity and
specificity of the questionnaire diagnosis were 83.57%
and 93.56% respectively.
The sensitivity analysis performed using modified
algorithms for definitions of health claims diagnosis did
Table 1 Characteristics of Toronto School Children with Asthma Questionnaire and Health Claims Data, 2006
a
Variable Respondents
n = 2884
n (%)
Non-respondents
n = 2735
n (%)
P-value
Physician Diagnosis of asthma (n = 5461) 438 (15.71%) 409 (15.34%) 0.73
Male sex (n = 5573) 1459 (50.84%) 1313 (48.58%) 0.09
Mean age in years (n = 4781) 6.75 6.72 0.20
Income adequacy (n = 5241) <0.0001
Lowest income 469 (16.82%) 466 (19.00%)
Lower middle 568 (20.37%) 592 (24.14%)
Upper middle 577 (20.69%) 624 (25.45%)
Highest income 1175 (42.13%) 770 (31.40%)
Highest level of education (n = 5421) <0.0001
Less than high school 189 (6.75%) 267 (10.19%)
Completed high school 278 (9.92%) 340 (12.98%)
Completed postsecondary education 879 (31.37%) 962 (36.73%)
Completed post graduate education 1456 (51.96%) 1050 (40.09%)
Number of visits to health care provider in the last year (n = 5237) <0.0001
0 678 (24.85%) 742 (29.57%)
1-4 1471 (53.92%) 1213 (48.35%)
>=5 579 (21.22%) 554 (22.08%)
Physician visits in last year (n = 5237) <0.0001
No regular physician 678 (24.85%) 742 (29.57%)
Pediatrician only 936 (34.31%) 771 (30.73%)
General Practitioner only 486 (17.82%) 375 (14.95%)
Pediatrician & General Practitioner 628 (23.02%) 621 (24.75%)
Environmental tobacco smoke exposure in home (n = 5383) 302 (10.94%) 328 (12.51%) 0.07
aRespondents are T-CHEQ participants who agreed to health claims data linkage while non-respondents did not agree and are therefore not included in the
study population. The T-CHEQ study was a population-based sample.
Table 2 Questionnaire
a Asthma Diagnosis versus Health
Claims
b Diagnosis (n = 2782)
Health Claims + Health Claims - Total
Questionnaire + 346 91 437
Questionnaire - 240 2105 2345
Total 586 2196 2782
a Positive response to questions “Has your child ever had asthma?” and “Was
this diagnosed by a physician?”
bAlgorithm of one asthma hospitalization and/or two asthma physician visit
claims within two years
Kappa = 0.60 (95% CI 0.56, 0.64)
Sensitivity = 59.04% Specificity = 95.86% (Health Claims reference standard)
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shown).
We observed moderate agreement (kappa = 0.60)
between questionnaire asthma definitions and health
claims asthma definitions. Good agreement (kappa = 0.75)
was observed when those with asthma-related symptoms
were excluded.
Discussion
Our findings concur with other literature that suggests
that questionnaire asthma diagnosis is specific but not
sensitive for asthma [14-17]. As expected, compared with
questionnaires that use a definition of “wheezing in the
last twelve months” to define the population with asthma,
our definition of physician diagnosed asthma was more
specific but less sensitive [18]. In epidemiologic studies
that estimate prevalence, a highly sensitive test is prefer-
able; whereas, studies that estimate risk require more spe-
cific tests [19].
Excluding children with asthma-related symptoms
from the sample increased the sensitivity (from 59% to
84%) and overall agreement (kappa increased from 0.60
to 0.75) between questionnaire and health claims diag-
noses. Children with asthma-related symptoms may
represent a substantial proportion of under-diagnosed
asthma. This may have implications for cohort studies
producing risk estimates [20] for putative risk factors for
asthma incidence. Our findings support the practice of
excluding children with asthma-related symptoms from
the control group in epidemiological studies in order to
decrease misclassification bias [20]. A limitation to this
approach is the inflation of the odds ratio that occurs
and the divergence of the odds ratio from the relative
risk, making it impossible to calculate population-attribu-
table risk from an exposure.
The diagnosis of asthma is problematic as subjects are
often asymptomatic with normal physical examinations
and normal pulmonary function tests between exacerba-
tions [21]. This problem is compounded in children as
they are often unable to do pulmonary function testing
would might help to clarify the diagnosis. As such, the
diagnosis often relies on symptom report which is subject
to significant recall bias [22]. Given these limitations,
health claims databases are a useful source of information
as they capture data at the time of asthma exacerbation.
A larger issue in the study of asthma is that there is
no accepted gold standard to confirm the diagnosis;
therefore, studies evaluating diagnostic tests must use an
imperfect reference standard. The accuracy of the test
being evaluated is a measure of how closely it correlates
with the reference standard. Given that the question-
naire and the health claims diagnosis measure different
aspects of physician-diagnosed asthma, it is not surpris-
ing that the questionnaire has good validity against the
health claims reference standard.
We have capitalized on the population-based data
available through our universal health care system to
validate the questionnaire asthma diagnosis in our T-
CHEQ population. The results of this study may not be
generalizable to a population that does not have equal
access to health care.
This study is however the largest validation study
reported to date and gives evidence that parental report
on questionnaire is a highly specific method for identify-
ing children with asthma in Canada.
Conclusions
Parental proxy report of asthma diagnosis by question-
naire has low sensitivity but high specificity as an
asthma prevalence measure for epidemiological studies.
Excluding children with asthma-related symptoms from
non-asthma control groups will result in less misclassifi-
cation bias.
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Table 3 Questionnaire
a Asthma Diagnosis versus Health
Claims
b Diagnosis, excluding children with “asthma-
related symptoms” (n = 1826)
Health Claims + Health Claims - Total
Questionnaire + 346 91 437
Questionnaire - 68 1321 1389
Total 414 1412 1826
a Positive answer to questions “Has your child ever had asthma?” and “Was
this diagnosed by a physician?”
b Algorithm of one asthma hospitalization and/or two asthma physician visit
claims within two years
Kappa = 0.75 (95% CI = 0.72, 0.79)
Sensitivity = 83.57% Specificity = 93.56% (Health Claims Reference Standard)
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